MEYER COLIN JOHN (Chief Medical Officer) sold 3.2% of their position (2.74K shares) of REATA PHARMACEUTICALS INC on the open market
Open‑market sale worth $463.1K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 8/17/2023ACC: 0001209191-23-046294
Officer· Chief Medical Officer
Since Jan 2019
-2.74K
Net shares
Net seller
$463.1K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
2.74K disposed
Non-Derivative Transactions2
Class A common stock
Direct
Shares
−2.14K
Price / share
$169.07
Trade value
$362.48K
% of position
2.5%
8/15/2023
84.37K→82.23K
Class A common stock
Direct
Shares
−596.00
Price / share
$168.74
Trade value
$100.57K
% of position
0.7%
8/16/2023
82.23K→81.63K
Total
Net shares
−2.74K
Net value
-$463.05K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A common stock Direct | 8/15/2023 | S · Sale | −2.14K | $169.07 | $362.48K | 2.5% | 84.37K | 82.23K |
| Class A common stock Direct | 8/16/2023 | S · Sale | −596.00 | $168.74 | $100.57K | 0.7% | 82.23K | 81.63K |
| Total | −2.74K | -$463.05K | ||||||
Derivative Transactions0
No derivative transactions reported